Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.73
+2.46 (1.20%)
AAPL  273.84
+7.66 (2.88%)
AMD  209.65
+13.05 (6.64%)
BAC  49.80
-1.27 (-2.49%)
GOOG  309.27
-2.42 (-0.78%)
META  635.83
-1.42 (-0.22%)
MSFT  386.81
+2.34 (0.61%)
NVDA  191.83
+0.28 (0.15%)
ORCL  145.75
+4.44 (3.14%)
TSLA  407.08
+7.25 (1.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.